FDA approves menthol vapes, drawing criticism from health advocates

  • 📰 washingtonpost
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 72%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

The decision arrives as the FDA is criticized for failing to rein in illegal but widely available flavored vaping products that appeal to young people.

The Food and Drug Administration on Friday approved the first menthol-flavored e-cigarette products, drawing swift criticism from some public health advocates while signaling the agency believes vapes can help adult smokers quit smoking tobacco.increasing criticism for failing to rein in illegal but widely available flavored vaping products that appeal to young people and comes amid

E-cigarette products are regulated as tobacco products because they often contain nicotine, which is addictive. The agency stressed Friday that the approval “does not mean these tobacco products are safe” and thatIn recent years, the agency has cited public health risks in denying marketing approvals for thousands of e-cigarettes — until Friday, it had approved just 23 tobacco-flavored products. Anti-tobacco groups say most teens prefer flavored or menthol vape products.

The decision may boost the multibillion dollar U.S. e-cigarette industry. Altria did not return a request for comment.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 95. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Baby Formula Recall Update as FDA Issues Highest Level of ConcernThe product's nutrition doesn't meet FDA requirements, and at least one infant was diagnosed with anemia.
Source: Newsweek - 🏆 468. / 52 Read more »

Independent FDA Panel Endorses New Alzheimer’s Disease TreatmentAn FDA advisory panel unanimously gave a green light on Monday to the Alzheimer’s disease treatment donanemab for use during early stages of the disease.
Source: WebMD - 🏆 709. / 51 Read more »